Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

2.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.3K
Standard Precaution01:26

Standard Precaution

2.4K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.4K
Pharmacovigilance01:19

Pharmacovigilance

1.4K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

351
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
351
Hand hygiene01:23

Hand hygiene

5.0K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectory Modelling of Prognostic Biomarkers Linked to Liver Cancer Risk: A Systematic Review.

Liver cancer·2026
Same author

Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Pharmacist-Led Discharge Care to Reduce Postdischarge Health Care Utilization: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trial.

Thrombosis research·2026
Same author

Chronic hepatitis in horses with persistent equine hepacivirus infection.

Equine veterinary journal·2025
Same author

Concern regarding "A novel decision tree for performing risk assessments of biologics in a health-system setting".

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025

Related Experiment Video

Updated: Nov 11, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.5K

Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface Contamination.

Michael Gabay1, Philip Johnson2, John Fanikos3

  • 1Drug Information Group, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|March 27, 2021
PubMed
Summary
This summary is machine-generated.

Experts developed 11 consensus statements on hazardous drug (HD) surface contamination monitoring. These guidelines aim to improve safe handling practices and inform stakeholders across the drug supply chain, policy, and healthcare.

Keywords:
drug safetyhazardous drugsmedication safetysurface contamination monitoringwipe sampling

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.0K
A Filter-based Surface Enhanced Raman Spectroscopic Assay for Rapid Detection of Chemical Contaminants
08:13

A Filter-based Surface Enhanced Raman Spectroscopic Assay for Rapid Detection of Chemical Contaminants

Published on: February 19, 2016

9.6K

Related Experiment Videos

Last Updated: Nov 11, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.5K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.0K
A Filter-based Surface Enhanced Raman Spectroscopic Assay for Rapid Detection of Chemical Contaminants
08:13

A Filter-based Surface Enhanced Raman Spectroscopic Assay for Rapid Detection of Chemical Contaminants

Published on: February 19, 2016

9.6K

Area of Science:

  • Environmental Health
  • Occupational Safety
  • Pharmaceutical Sciences

Background:

  • Hazardous drug (HD) surface contamination poses risks to healthcare professionals and patients.
  • Current monitoring practices for HD surface contamination vary significantly.
  • There is a need for standardized guidelines for HD surface contamination monitoring.

Purpose of the Study:

  • To convene subject matter experts to develop consensus statements on hazardous drug (HD) surface contamination monitoring.
  • To provide recommendations for stakeholders in the drug supply chain, policy, and healthcare arenas.
  • To enhance the scope and adoption of HD surface contamination monitoring.

Main Methods:

  • The 2020 Safe to Touch Consensus Conference brought together experts in HD handling and monitoring.
  • An expert panel led the conference, with input from a reaction panel and expert speakers.
  • Discussions covered the health impacts of HD contamination, regulations, monitoring technologies, and testing variables.

Main Results:

  • Eleven consensus statements and recommendations regarding HD surface contamination monitoring were developed.
  • The consensus statements aim to educate stakeholders on the impact of HD contamination.
  • The recommendations encourage institutions to set goals for implementing monitoring practices.

Conclusions:

  • Widespread dissemination of consensus statements is crucial for education and increased monitoring.
  • Healthcare institutions handling HDs should establish short- and long-term implementation goals.
  • Standardized monitoring of hazardous drug surface contamination is essential for safety.